Literature DB >> 12081582

Health care utilization among patients with chronic kidney disease.

Samina S Khan1, Waqar H Kazmi, Rekha Abichandani, Hocine Tighiouart, Brian J G Pereira, Annamaria T Kausz.   

Abstract

BACKGROUND: Higher hospitalization rates among end-stage renal disease (ESRD) patients impose a substantial burden on the U.S. health care system. Early identification of patients with chronic kidney disease (CKD) and determination of factors associated with increased morbidity may lead to appropriate interventions to attenuate the complications of CKD and possibly reduce future resource utilization.
METHODS: This retrospective cohort study of CKD patients in an outpatient nephrology clinic was performed to identify risk factors for hospitalization. The study population consisted of adults with elevated serum creatinine (females > or =1.5 mg/dL, males > or =2.0 mg/dL). Hospitalizations, hospital days and outpatient nephrology visits were examined.
RESULTS: Among the 259 patients, 123 (47%) were hospitalized during a median follow-up of 11.4 months. The number of hospitalizations and hospital days per patient-year at risk were 0.96 and 6.6, respectively. Cardiovascular disease/hypertension accounted for the majority of hospitalizations. In a multivariate regression analysis, older age (RR 1.01, 95% CI 1.00, 1.03) and presence of cardiac disease (RR 1.91, 95% CI 1.19, 3.07) were associated with higher risk of hospitalization while higher serum albumin (RR 0.58, 95% CI 0.35, 0.95) and higher hematocrit (RR 0.92, 95% CI 0.87, 0.97) were associated with lower risk of hospitalization. Higher serum albumin (RR 0.34, 95% CI 0.21, 0.55), higher hematocrit (RR 0.87, 95% CI 0.81, 0.93) and use of ACE-inhibitors (RR 0.63, 95% CI 0.47, 0.84) were associated with lower risk of subsequent hospital days. Erythropoietin (RR 1.47, 95% CI 1.11, 1.82) use was associated with higher risk of outpatient nephrology visits.
CONCLUSION: Certain potentially modifiable factors appear to be associated with increased resource utilization. It is hypothesized that attention to these factors may lead to improved outcomes in this patient population, which could result in reduced utilization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12081582     DOI: 10.1046/j.1523-1755.2002.00432.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  55 in total

1.  The care of patients with chronic kidney disease.

Authors:  Annamaria T Kausz; Andrew S Levey
Journal:  J Gen Intern Med       Date:  2002-08       Impact factor: 5.128

2.  Natural history of older adults with impaired kidney function: the InCHIANTI study.

Authors:  Sandra V Giannelli; Christophe E Graf; François R Herrmann; Jean-Pierre Michel; Kushang V Patel; Francesco Pizzarelli; Luigi Ferrucci; Jack Guralnik
Journal:  Rejuvenation Res       Date:  2011-09-28       Impact factor: 4.663

Review 3.  Renal protection in hypertensive patients: selection of antihypertensive therapy.

Authors:  René R Wenzel
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Comparative cost-benefit analyses of paricalcitol and calcitriol in stage 4 chronic kidney disease from the perspective of a health plan.

Authors:  Anca Gal-Moscovici; Stuart M Sprague
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 5.  Treatment rationale for coronary heart disease in advanced CKD.

Authors:  K Lopau; C Wanner
Journal:  Herz       Date:  2021-02-10       Impact factor: 1.443

6.  Poor accordance to a DASH dietary pattern is associated with higher risk of ESRD among adults with moderate chronic kidney disease and hypertension.

Authors:  Tanushree Banerjee; Deidra C Crews; Delphine S Tuot; Meda E Pavkov; Nilka Rios Burrows; Austin G Stack; Rajiv Saran; Jennifer Bragg-Gresham; Neil R Powe
Journal:  Kidney Int       Date:  2019-03-04       Impact factor: 10.612

7.  An extended terminal half-life for darbepoetin alfa: results from a single-dose pharmacokinetic study in patients with chronic kidney disease not receiving dialysis.

Authors:  Desmond Padhi; Liyun Ni; Blaire Cooke; Rafael Marino; Graham Jang
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

8.  Estimating the causal effects of chronic disease combinations on 30-day hospital readmissions based on observational Medicaid data.

Authors:  Sabrina Casucci; Li Lin; Sharon Hewner; Alexander Nikolaev
Journal:  J Am Med Inform Assoc       Date:  2018-06-01       Impact factor: 4.497

9.  Are Ambulatory Care-Sensitive Conditions the Fulcrum of Hospitalizations for CKD Patients?

Authors:  Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-06       Impact factor: 8.237

10.  Physical activity and change in estimated GFR among persons with CKD.

Authors:  Cassianne Robinson-Cohen; Alyson J Littman; Glen E Duncan; Noel S Weiss; Michael C Sachs; John Ruzinski; John Kundzins; Denise Rock; Ian H de Boer; T Alp Ikizler; Jonathan Himmelfarb; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.